EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PRNP E146G mutation inherited prion disease: distinctive clinical, pathological and fluid biomarker features

Thomas Coysh, Zane Jaunmuktane, Laszlo L P Hosszu, Nour Majbour, Fuquan Zhang, Tracy Campbell, Lee Darwent, Marcelo Barria Matus, Edgar Chan, Leah Holm-Mercer, Tze How Mok, Jonathan D F Wadsworth und 7 weitere

Journal of Neurology · 2025

DOI: 10.1007/s00415-025-13022-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology, 2025. Verfasst von Thomas Coysh und 18 weiteren Autor:innen. Beteiligte Einrichtung: MRC Prion Unit at UCL, UCL Institute of Prion Diseases, 33 Cleveland Street, London, W1W 7FF, UK. Hauptthemen laut MEDLINE: Mutation, Prion Diseases, Prion Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Alzheimer’s Research UK, UCLH Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited prion diseases (IPDs) are phenotypically diverse neurodegenerative conditions caused by mutations in the prion protein gene ( PRNP ). We describe IPD due to a novel PRNP E146G mutation in a 50-year-old man presenting with slowly progressive dysarthria, prominent myoclonus especially in the lower limbs, and less prominent gait ataxia, pyramidal and extrapyramidal signs. Cognitive impairment was not overt at disease onset. MRI revealed cerebellar atrophy and white matter hyperintensities. His 46-year-old sister carries the mutation and has subtle gait ataxia and dysarthria. Both patients exhibit a distinctive fluid biomarker profile: in CSF S100B is > twofold upper limit of normal, total tau is moderately elevated, and neurofilament light chain, 14-3-3 and RT-QuIC are negative; in plasma there is marked elevation of GFAP but repeatedly normal neurofilament light chain. The proband’s father died aged 55 following an 8-year dementing illness with similar presentation. Post-mortem revealed cerebellar cortical atrophy and profuse large PrP amyloid plaques across cerebral and cerebellar grey matter. Immunoblotting identified low molecular weight protease-resistant PrP fragments. E146G mutation IPD broadly fits into the historical Gerstmann–Sträussler–Scheinker disease spectrum but, based on deep clinical phenotyping of this initial pedigree, we highlight some distinctive features, which may aid in identification of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationPrion DiseasesPrion ProteinsFemaleHumansMaleMiddle AgedBiomarkersBrain

Stichwörter der Autor:innen

BiomarkersInherited prion diseaseMutationNeurodegenerationPathologyPrion

Substanzen

BiomarkersPrion ProteinsPRNP protein, human

Autor:innen und Institutionen

  • MRC Prion Unit at UCL, UCL Institute of Prion Diseases, 33 Cleveland Street, London, W1W 7FF, UK.
  • National Prion Clinic, University College London Hospitals NHS Foundation Trust, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.
  • Department of Neuropathology, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.
  • National CJD Research & Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.
  • Department of Neurology, Northampton General Hospital NHS Trust, Cliftonville, Northampton, NN1 5BD, UK.
  • Department of Neuropathology, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK.

Förderung

  • Medical Research Council
  • Alzheimer’s Research UK
  • UCLH Biomedical Research Centre
  • National Institute for Health and Care Research
  • Association of British Neurologists

Zitieren

APA

Coysh, T., Jaunmuktane, Z., Hosszu, L. L. P., Majbour, N., Zhang, F., Campbell, T., Darwent, L., Matus, M. B., Chan, E., Holm-Mercer, L., Mok, T. H., Wadsworth, J. D. F., Bieschke, J., Nithi, K., Brandner, S., Smith, C., Esiri, M., Collinge, J., & Mead, S. (2025). PRNP E146G mutation inherited prion disease: distinctive clinical, pathological and fluid biomarker features. Journal of Neurology. https://doi.org/10.1007/s00415-025-13022-2

Vancouver

Coysh T, Jaunmuktane Z, Hosszu LLP, Majbour N, Zhang F, Campbell T, et al. PRNP E146G mutation inherited prion disease: distinctive clinical, pathological and fluid biomarker features. Journal of Neurology. 2025. doi:10.1007/s00415-025-13022-2

BibTeX
@article{Coysh2025,
  author = {Coysh, Thomas and Jaunmuktane, Zane and Hosszu, Laszlo L P and Majbour, Nour and Zhang, Fuquan and Campbell, Tracy and Darwent, Lee and Matus, Marcelo Barria and Chan, Edgar and Holm-Mercer, Leah and Mok, Tze How and Wadsworth, Jonathan D F and Bieschke, Jan and Nithi, Kannan and Brandner, Sebastian and Smith, Colin and Esiri, Margaret and Collinge, John and Mead, Simon},
  title = {PRNP E146G mutation inherited prion disease: distinctive clinical, pathological and fluid biomarker features},
  journal = {Journal of Neurology},
  year = {2025},
  doi = {10.1007/s00415-025-13022-2}
}
Kostenlos starten →